My major research interest is in radiation therapy for lymphomas, genitourinary cancers—including prostate cancer, bladder cancer and seminoma—and late effects of treatment, especially second cancers. Current research activities include study of image guided precision radiotherapy. I also have a long-standing interest in cancer classification with an emphasis on staging and prognostic factors. In addition, my current interests include the application of modern information and communication technologies in cancer control.
Mary K Gospodarowicz
Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone.
J Clin Oncol. 2004 Jul 15;22(14_suppl):6521
J Clin Oncol. 2004 Jul 15;22(14_suppl):4519
A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013.
J Clin Oncol. 2011 Mar;29(7_suppl):3
J Clin Oncol. 2011 Mar;29(7_suppl):20
Clin Oncol (R Coll Radiol). 2016 Dec 05;:
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Int J Radiat Oncol Biol Phys. 2016 Sep 28;:
Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer.
Radiother Oncol. 2016 Nov 9;:
Long-Term Outcomes of a Phase 2 Trial of Moderate Hypofractionated Image Guided Intensity Modulated Radiation Therapy (IG-IMRT) for Localized Prostate Cancer.
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S32-S33
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S14-S15
Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Will Evaluating Dose to Coronary Arteries Improve Risk Estimates?
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2S):S126
Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Professor, Department of Radiation Oncology, University of Toronto
President, Union for International Cancer Control (UICC)